Literature DB >> 2166666

Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.

S Janssen1, D A Piers, M H van Rijswijk, S Meijer, E Mandema.   

Abstract

This study describes the results of scintigraphy with 99mTc-labeled methylene-diphosphonate (99mTc-MDP) and pyrophosphate (99mTc-PYP) as a noninvasive test for the distribution of organ involvement in five different types of amyloidosis. Scintigraphy with 99mTc-labeled phosphates appeared to be a sensitive noninvasive screening test for the extent and the distribution of organ involvement in systemic AA and systemic AL amyloidosis as well as in local bronchial amyloid, local dermal amyloid, and familial amyloidotic polyneuropathy. Echocardiography, however, was more sensitive for demonstrating cardiac involvement in systemic amyloidosis than 99mTc-MDP or 99mTc-PYP scintigraphy. 99mTc-MDP images showed a better contrast than 99mTc-PYP images, although there was no difference in the extent or the intensity of soft-tissue uptake.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166666     DOI: 10.1007/BF00998166

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  37 in total

1.  Technetium-99m-diphosphonate accumulation in amyloid.

Authors:  J D VanAntwerp; R E O'Mara; M J Pitt; S Walsh
Journal:  J Nucl Med       Date:  1975-03       Impact factor: 10.057

2.  Scanning for soft-tissue amyloid.

Authors:  J L Bada; L Padro; C Cervera
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

3.  Scanning for soft-tissue amyloid.

Authors:  R W Kula; W K Engel; B R Line
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321

4.  Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report.

Authors:  J A Vanek; S A Cook; R M Bukowski
Journal:  J Nucl Med       Date:  1977-11       Impact factor: 10.057

5.  Bone scan in a case of amyloidosis.

Authors:  J W Moyle; S M Spies
Journal:  Clin Nucl Med       Date:  1980-02       Impact factor: 7.794

6.  Mechanism of factor X deficiency in systemic amyloidosis.

Authors:  B Furie; L Voo; K P McAdam; B C Furie
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

7.  Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.

Authors:  M A Gertz; M L Brown; M F Hauser; R A Kyle
Journal:  Arch Intern Med       Date:  1987-06

8.  Soft tissue uptake of bone seeking radionuclide in amyloidosis.

Authors:  R A Yood; M Skinner; A S Cohen; V W Lee
Journal:  J Rheumatol       Date:  1981 Sep-Oct       Impact factor: 4.666

9.  Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.

Authors:  T A Wizenberg; J Muz; Y H Sohn; W Samlowski; A M Weissler
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

10.  Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.

Authors:  V W Lee; A G Caldarone; R H Falk; A Rubinow; A S Cohen
Journal:  Radiology       Date:  1983-07       Impact factor: 11.105

View more
  15 in total

1.  Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.

Authors:  Pradeep Bhambhvani; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-09-08       Impact factor: 5.952

2.  Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.

Authors:  Sabahat Bokhari; Rachelle Morgenstern; Richard Weinberg; Mona Kinkhabwala; Demetrios Panagiotou; Adam Castano; Albert DeLuca; Andrew Kontak; Zhezhen Jin; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2016-08-31       Impact factor: 5.952

3.  Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin.

Authors:  C Aprile; G Marinone; R Saponaro; C Bonino; G Merlini
Journal:  Eur J Nucl Med       Date:  1995-12

4.  Diffuse Myocardial Uptake of (99m)Tc-HDP in Multiple Myeloma.

Authors:  Koray Demirel; Murat Sadic; Meliha Korkmaz; Aylin Comak; Hasan Ikbal Atilgan; Gökhan Koca
Journal:  Nucl Med Mol Imaging       Date:  2013-05-18

Review 5.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 6.  Nuclear imaging for cardiac amyloidosis.

Authors:  Walter Noordzij; Andor W J M Glaudemans; Simone Longhi; Riemer H J A Slart; Massimiliano Lorenzini; Bouke P C Hazenberg; Claudio Rapezzi
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

7.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

8.  Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.

Authors:  R Saïle; M Deveaux; E Hachulla; J Descamps; B Duquesnoy; X Marchandise
Journal:  Eur J Nucl Med       Date:  1993-02

9.  Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging.

Authors:  Naoki Ezawa; Nagaaki Katoh; Kazuhiro Oguchi; Tsuneaki Yoshinaga; Masahide Yazaki; Yoshiki Sekijima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-10       Impact factor: 9.236

Review 10.  Nuclear imaging in cardiac amyloidosis.

Authors:  A W J M Glaudemans; R H J A Slart; C J Zeebregts; N C Veltman; R A Tio; B P C Hazenberg; R A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-21       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.